{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:51:55Z","timestamp":1791499915692,"version":"4.3.4"},"reference-count":36,"publisher":"Wiley","issue":"13","license":[{"start":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T00:00:00Z","timestamp":1431475200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T00:00:00Z","timestamp":1431475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"NIH\/NCI","award":["CA140468"],"award-info":[{"award-number":["CA140468"]}]},{"name":"NIH\/NCI","award":["CA168601"],"award-info":[{"award-number":["CA168601"]}]},{"name":"NIH\/NCI","award":["CA179970"],"award-info":[{"award-number":["CA179970"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostate"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1002\/pros.23015","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T13:35:29Z","timestamp":1431524129000},"page":"1341-1353","source":"Crossref","is-referenced-by-count":94,"title":["Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition"],"prefix":"10.1002","volume":"75","author":[{"given":"Chengfei","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Urology; University of California at Davis; Sacramento California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lou","sequence":"additional","affiliation":[{"name":"Department of Urology; University of California at Davis; Sacramento California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Department of Urology; University of California at Davis; Sacramento California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yezi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Urology; University of California at Davis; Sacramento California"},{"name":"Graduate Program in Pharmacology and Toxicology; University of California at Davis; Sacramento California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Urology; University of California at Davis; Sacramento California"},{"name":"Comprehensive Cancer Center; University of California at Davis; Sacramento California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen C.","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Urology; University of California at Davis; Sacramento California"},{"name":"Graduate Program in Pharmacology and Toxicology; University of California at Davis; Sacramento California"},{"name":"Comprehensive Cancer Center; University of California at Davis; Sacramento California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,5,13]]},"reference":[{"key":"10.1002\/pros.23015-BIB0001|pros23015-cit-0001","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1002\/pros.23015-BIB0002|pros23015-cit-0002","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMoa1405095","article-title":"Enzalutamide in metastatic prostate cancer before chemotherapy","volume":"371","author":"Beer","year":"2014","journal-title":"New Engl J Med"},{"key":"10.1002\/pros.23015-BIB0003|pros23015-cit-0003","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature13229","article-title":"Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer","volume":"510","author":"Asangani","year":"2014","journal-title":"Nature"},{"key":"10.1002\/pros.23015-BIB0004|pros23015-cit-0004","doi-asserted-by":"crossref","first-page":"19359","DOI":"10.1074\/jbc.M113.477216","article-title":"Differential androgen deprivation therapies with anti-androgens casodex\/bicalutamide or MDV3100\/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis","volume":"288","author":"Lin","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1002\/pros.23015-BIB0005|pros23015-cit-0005","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1038\/cddis.2013.270","article-title":"Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling","volume":"4","author":"Lin","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1002\/pros.23015-BIB0006|pros23015-cit-0006","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/pros.22741","article-title":"Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells","volume":"74","author":"Liu","year":"2014","journal-title":"Prostate"},{"key":"10.1002\/pros.23015-BIB0007|pros23015-cit-0007","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccr.2009.01.009","article-title":"Inflammation and cancer: IL-6 and STAT3 complete the link","volume":"15","author":"Bromberg","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1002\/pros.23015-BIB0008|pros23015-cit-0008","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1158\/1078-0432.CCR-13-3296","article-title":"Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer","volume":"20","author":"Liu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pros.23015-BIB0009|pros23015-cit-0009","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G","article-title":"Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway","volume":"42","author":"Lou","year":"2000","journal-title":"Prostate"},{"key":"10.1002\/pros.23015-BIB0010|pros23015-cit-0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/pros.10110","article-title":"Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice","volume":"52","author":"DeMiguel","year":"2002","journal-title":"Prostate"},{"key":"10.1002\/pros.23015-BIB0011|pros23015-cit-0011","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1947601911409744","article-title":"Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer","volume":"2","author":"Liu","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1002\/pros.23015-BIB0012|pros23015-cit-0012","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/pros.22583","article-title":"Functional p53 determines docetaxel sensitivity in prostate cancer cells","volume":"73","author":"Liu","year":"2013","journal-title":"Prostate"},{"key":"10.1002\/pros.23015-BIB0013|pros23015-cit-0013","article-title":"Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer","author":"Liu","year":"2015","journal-title":"Cancer Res"},{"key":"10.1002\/pros.23015-BIB0014|pros23015-cit-0014","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1158\/1535-7163.MCT-13-0208","article-title":"Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer","volume":"12","author":"Zhu","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/pros.23015-BIB0015|pros23015-cit-0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1530\/ERC-14-0107","article-title":"Upregulation of glucose metabolism by NF-kappaB2\/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells","volume":"21","author":"Cui","year":"2014","journal-title":"Endocr-Relat Cancer"},{"key":"10.1002\/pros.23015-BIB0016|pros23015-cit-0016","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1158\/1535-7163.MCT-13-0095","article-title":"Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer","volume":"12","author":"Li","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/pros.23015-BIB0017|pros23015-cit-0017","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.clinbiochem.2014.05.066","article-title":"Recent advances in head and neck squamous cell carcinoma-a review","volume":"47","author":"Safdari","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1002\/pros.23015-BIB0018|pros23015-cit-0018","first-page":"370","article-title":"Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells","volume":"9","author":"Lee","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pros.23015-BIB0019|pros23015-cit-0019","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccr.2009.10.015","article-title":"The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors","volume":"16","author":"Hedvat","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1002\/pros.23015-BIB0020|pros23015-cit-0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells: Role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1002\/pros.23015-BIB0021|pros23015-cit-0021","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2353\/ajpath.2008.071054","article-title":"Stat3 promotes metastatic progression of prostate cancer","volume":"172","author":"Abdulghani","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1002\/pros.23015-BIB0022|pros23015-cit-0022","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/pros.21409","article-title":"Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion","volume":"72","author":"Sun","journal-title":"Prostate"},{"key":"10.1002\/pros.23015-BIB0023|pros23015-cit-0023","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.juro.2010.03.034","article-title":"Skeletal related events, bone metastasis and survival of prostate cancer: A population based cohort study in Denmark (1999 to 2007)","volume":"184","author":"Norgaard","year":"2010","journal-title":"J Urol"},{"key":"10.1002\/pros.23015-BIB0024|pros23015-cit-0024","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1016\/j.biomaterials.2014.01.062","article-title":"Species-specific homing mechanisms of human prostate cancer metastasis in tissue engineered bone","volume":"35","author":"Holzapfel","year":"2014","journal-title":"Biomaterials"},{"key":"10.1002\/pros.23015-BIB0025|pros23015-cit-0025","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1002\/pros.23015-BIB0026|pros23015-cit-0026","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1158\/1078-0432.CCR-09-0640","article-title":"Interleukin-6 regulates androgen synthesis in prostate cancer cells","volume":"15","author":"Chun","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pros.23015-BIB0027|pros23015-cit-0027","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/pros.22819","article-title":"Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST)","volume":"74","author":"Zhu","year":"2014","journal-title":"Prostate"},{"key":"10.1002\/pros.23015-BIB0028|pros23015-cit-0028","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1002\/pros.23015-BIB0029|pros23015-cit-0029","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/jso.22134","article-title":"Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer","volume":"105","author":"Chu","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1002\/pros.23015-BIB0030|pros23015-cit-0030","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1245\/s10434-011-1692-5","article-title":"Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells","volume":"19","author":"Tai","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1002\/pros.23015-BIB0031|pros23015-cit-0031","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1530\/ERC-11-0075","article-title":"Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells","volume":"18","author":"Knight","year":"2011","journal-title":"Endocr-Relat Cancer"},{"key":"10.1002\/pros.23015-BIB0032|pros23015-cit-0032","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","article-title":"The role of IL-6 and STAT3 in inflammation and cancer","volume":"41","author":"Hodge","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1002\/pros.23015-BIB0033|pros23015-cit-0033","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2007.12.020","article-title":"Autocrine IL-6 signaling: A key event in tumorigenesis?","volume":"13","author":"Grivennikov","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1002\/pros.23015-BIB0034|pros23015-cit-0034","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1021\/bi9009677","article-title":"The anti-helminthic niclosamide inhibits Wnt\/Frizzled1 signaling","volume":"48","author":"Chen","year":"2009","journal-title":"Biochem"},{"key":"10.1002\/pros.23015-BIB0035|pros23015-cit-0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.celrep.2014.01.013","article-title":"Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants","volume":"6","author":"An","year":"2014","journal-title":"Cell Rep"},{"key":"10.1002\/pros.23015-BIB0036|pros23015-cit-0036","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1074\/jbc.M108255200","article-title":"Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways","volume":"277","author":"Ueda","year":"2002","journal-title":"J Biol Chem"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23015","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23015","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pros.23015\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T14:41:44Z","timestamp":1596897704000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/pros.23015"}},"subtitle":["Niclosamide Inhibits Stat3 and Cell Migration"],"short-title":[],"issued":{"date-parts":[[2015,5,13]]},"references-count":36,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,9]]}},"URL":"https:\/\/doi.org\/10.1002\/pros.23015","archive":["Portico"],"relation":{},"ISSN":["0270-4137"],"issn-type":[{"value":"0270-4137","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5,13]]}}}